博客 · 最新 · 注明日期 · 有据可查
GLP-1，最新动态——2026 年发生了什么变化，数据说明了什么。
直接回答今年人们真正在搜索的问题，每篇文章都基于 FDA 处方信息和同行评议的试验。若要了解不变的基础知识，请从我们的GLP-1 指南开始。
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
本内容为教育性质，并非医疗建议。每篇文章均根据 FDA 处方信息和引用的临床试验整理而成；查看我们的编辑政策，了解这些内容如何撰写和更新。